Measuring outcomes as a function of baseline severity of ischemic stroke

Cerebrovascular Diseases

Volumn 18, Issue 2, 2004, Pages 124-129

  Adams Jr , Harold P ^a   Leclerc, Jacques R ^c   Bluhmki, Eric ^d   Clarke, William ^b   Hansen, Michael D ^b   Hacke, Werner ^e  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c ELI LILLY AND COMPANY   (United States)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

^e UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Modified Rankin Scale; National Institutes of Health Stroke Scale; Outcomes; Stroke trials

Indexed keywords

ABCIXIMAB;

ANALYTIC METHOD; ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; MAJOR CLINICAL STUDY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM;

ACUTE DISEASE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 4043181400     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079260     Document Type: Article

References (8)

1. Brott T, Adams HP Jr, Olinger CP, et al: Measurements of acute cerebral infarction: A clinical examination scale. Stroke 1989;20:864-870.
2. Adams HP Jr, Davis PH, Leira EC, et al: Baseline NIH Stroke Scale score strongly predicts outcome after stroke. Neurology 1999;53:126-131.
3. The NINDS t-PA Stroke Study Group: Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-2118.
4. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators: Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: A randomized controlled trial. JAMA 1998;279:1265-1272.
5. Bamford JM, Sandercock PAG, Warlow CP, Slattery J: Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1989;20:828.
6. Hacke W, Kaste M, Fieschi C, et al: Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
7. Hacke W, Kaste M, Fieschi C, et al: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
8. Fisher M, for the Stroke Therapy Academic Industry Roundtable: Recommendations for advancing development of acute stroke therapies. Stroke therapy academic industry round-table 3. Stroke 2003;34:1539-1546.